耐世特(1316.HK)涨近7% 股价创2019年5月以来新高
格隆汇1月12日丨耐世特(1316.HK)拉升一度涨7.23%报10.38港元,股价创2019年5月以来新高,市值260亿港元。耐世特是特斯拉产业链股和自动驾驶概念股。公司是全球领先的转向及动力传动供货商之一,主要产品有:转向系统及零部件,包括EPS、HPS及转向管柱;及动力传动系统及零部件,包括半轴、中间传动轴及传动轴万向节。中信证券近日指出,短期看,耐世特基本面健康恢复而股价超跌,是加仓好机会。长期看,认为2021年有望成为L3级自动驾驶的大年,公司作为线控转向龙头企业未来有望受益,给予12个月目标价16.00港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.